179 related articles for article (PubMed ID: 7294537)
21. [Ultrastructural diagnostic problems of pleural tumors. A study of 125 cases (author's transl)].
Stoebner P; Bernaudin JF; Adnet JJ; Basset F
Rev Fr Mal Respir; 1979; 7(3):265-76. PubMed ID: 573917
[TBL] [Abstract][Full Text] [Related]
22. Scope of scanning electron microscopy, transmission electron microscopy and freeze fracture technique in diagnostic cytology of effusions.
Mukherjee TM; Smith K; Swift JG
Scan Electron Microsc; 1983; (Pt 3):1317-27. PubMed ID: 6648341
[TBL] [Abstract][Full Text] [Related]
23. [Value of cytological tests in the diagnosis of malignant pleurisies].
Mouriquand C; Kalb JC; Pison H; Queneau P; Thonnier C
Poumon Coeur; 1969; 25(2):141-61. PubMed ID: 5366040
[No Abstract] [Full Text] [Related]
24. [Malignant mesothelioma of the pleura. Morphometric study].
Serio G; Caniglia DM; Pennella A; Giardina C; Dalena AM; Serio R; Lettini T; Ricco R
Pathologica; 1997 Apr; 89(2):122-7. PubMed ID: 9411357
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructural diagnosis of pleural tumors.
Stoebner P; Brambilla E
Pathol Res Pract; 1982; 173(4):402-16. PubMed ID: 6889732
[TBL] [Abstract][Full Text] [Related]
26. Qualitative distinctive differences between the vacuoles of mesothelioma cells and of cells from metastatic carcinoma exfoliated in pleural fluid.
Boon ME; Veldhuizen RW; Ruinaard C; Snieders MW; Kwee WS
Acta Cytol; 1984; 28(4):443-9. PubMed ID: 6589924
[TBL] [Abstract][Full Text] [Related]
27. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
28. [Primary nonspecific chronic pleurisy (author's transl)].
Knolle H; Heinicke G; Matzel W
Arch Geschwulstforsch; 1977; 47(3):210-9. PubMed ID: 907442
[TBL] [Abstract][Full Text] [Related]
29. Cytologic criteria used to diagnose adenocarcinoma in pleural effusions.
Bottles K; Reznicek MJ; Holly EA; Ahn DK; Layfield LJ; Cohen MB
Mod Pathol; 1991 Nov; 4(6):677-81. PubMed ID: 1788258
[TBL] [Abstract][Full Text] [Related]
30. Early cytological diagnosis of diffuse malignant mesothelioma of the peritoneum: a case report.
Pomjanski N; Grote HJ; Sander O; Heikaus S; Müller KM; Böcking A
Diagn Cytopathol; 2008 Feb; 36(2):120-3. PubMed ID: 18181185
[TBL] [Abstract][Full Text] [Related]
31. Quantitative ultrastructural study of nuclei from exfoliated benign and malignant mesothelial cells and metastatic adenocarcinoma cells.
Dardick I; Butler EB; Dardick AM
Acta Cytol; 1986; 30(4):379-84. PubMed ID: 3461648
[TBL] [Abstract][Full Text] [Related]
32. Benign and malignant mesothelial lesions of the pleura: quantitative study.
Ranaldi R; Marinelli F; Barbatelli G; Mariuzzi G; Marzocchi F; Mancini AM; Pisani E; Ansuini G; Ricci M
Appl Pathol; 1986; 4(1-2):55-64. PubMed ID: 3580194
[TBL] [Abstract][Full Text] [Related]
33. [Cytology of pleural mesothelioma (author's transl)].
Mermolja M; Prlja D
Plucne Bolesti Tuberk; 1980; 32(3):89-94. PubMed ID: 7465690
[No Abstract] [Full Text] [Related]
34. The cytodiagnosis of malignant lymphomas and Hodgkin's disease in cerebrospinal, pleural and ascitic fluids.
Billingham ME; Rawlinson DG; Berry PF; Kempson RL
Acta Cytol; 1975; 19(6):547-56. PubMed ID: 1061472
[TBL] [Abstract][Full Text] [Related]
35. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
Marsan C; Gaulier A; Sabatier P; Garcia R
Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583
[TBL] [Abstract][Full Text] [Related]
36. Malignant mesothelioma. Cytopathology of 75 cases seen in a New Jersey community hospital.
Triol JH; Conston AS; Chandler SV
Acta Cytol; 1984; 28(1):37-45. PubMed ID: 6198832
[TBL] [Abstract][Full Text] [Related]
37. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
38. Differential diagnosis of malignant and reactive cells from serous effusions: image and texture analysis study.
García-Bonafé M; Moragas A
Anal Cell Pathol; 1996 Nov; 12(2):85-98. PubMed ID: 8986293
[TBL] [Abstract][Full Text] [Related]
39. Lipid-rich diffuse malignant mesothelioma: a case report.
Chang HT; Yantiss RK; Nielsen GP; McKee GT; Mark EJ
Hum Pathol; 2000 Jul; 31(7):876-9. PubMed ID: 10923929
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma.
Roboz J; Greaves J; Silides D; Chahinian AP; Holland JF
Cancer Res; 1985 Apr; 45(4):1850-4. PubMed ID: 3978644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
